The goal of this study is to determine whether QL blocks reduce opioid consumption following
arthroscopic hip surgery by decreasing postoperative pain. Considering the current opioid
epidemic, the responsibility of physicians to help prevent addiction, and the increasing
prevalence of arthroscopic hip surgeries, this study holds a tremendous potential benefit for
future patients.